Ensign Peak Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-194,933
| Closed | -$2.95M | – | 1757 |
|
|
2023
Q4 | $2.95M | Hold |
194,933
| – | – | 0.01% | 762 |
|
|
2023
Q3 | $3.91M | Hold |
194,933
| – | – | 0.01% | 637 |
|
|
2023
Q2 | $5.5M | Hold |
194,933
| – | – | 0.01% | 558 |
|
|
2023
Q1 | $3.35M | Hold |
194,933
| – | – | 0.01% | 675 |
|
|
2022
Q4 | $3.93M | Buy |
194,933
+43,080
| +28% | +$868K | 0.01% | 617 |
|
|
2022
Q3 | $3.29M | Buy |
151,853
+68,327
| +82% | +$1.48M | 0.01% | 635 |
|
|
2022
Q2 | $2.35M | Hold |
83,526
| – | – | 0.01% | 747 |
|
|
2022
Q1 | $3.85M | Hold |
83,526
| – | – | 0.01% | 661 |
|
|
2021
Q4 | $7.02M | Buy |
83,526
+48,946
| +142% | +$4.11M | 0.01% | 566 |
|
|
2021
Q3 | $2.3M | Sell |
34,580
-30,000
| -46% | -$2M | ﹤0.01% | 1034 |
|
|
2021
Q2 | $3.44M | Buy |
64,580
+56,280
| +678% | +$2.99M | 0.01% | 813 |
|
|
2021
Q1 | $360K | Hold |
8,300
| – | – | ﹤0.01% | 1648 |
|
|
2020
Q4 | $431K | Buy |
+8,300
| New | +$431K | ﹤0.01% | 1627 |
|